Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Biotech-bay symbols : ILMN save search
GRAIL Presents New Data on Galleri® and Its Methylation Platform at the Annual American Association for Cancer Research (AACR) Meeting
Published: 2024-03-27 (Crawled : 23:00) - biospace.com/
ILMN | $122.74 -1.38% -1.4% 1.2M
|
Health Technology
|
| O: 1.28%
H: 2.34%
C: 2.34%
galleri association cancer research meeting platform
Final Results From PATHFINDER Study of GRAIL’s Multi-Cancer Early Detection Blood Test Published in The Lancet
Published: 2023-10-05 (Crawled : 00:00) - biospace.com/
ILMN | $122.74 -1.38% -1.4% 1.2M
|
Health Technology
|
| O: 0.04%
H: 1.31%
C: 0.77%
test lancet blood results study
Point32Health and GRAIL Expand Pilot Access to Galleri® Multi-Cancer Early Detection Blood Test
Published: 2023-09-28 (Crawled : 15:00) - biospace.com/
ILMN | $122.74 -1.38% -1.4% 1.2M
|
Health Technology
|
| O: -2.17%
H: 2.66%
C: 1.49%
galleri test blood pilot
GRAIL to Present New Multi-Cancer Early Detection Data at the 2023 ASCO Annual Meeting
Published: 2023-05-22 (Crawled : 21:00) - biospace.com/
ILMN | $122.74 -1.38% -1.4% 1.2M
|
Health Technology
|
| O: 0.27%
H: 2.46%
C: 1.67%
asco meeting
GRAIL Presents Positive Analytical Validation Data on its Methylation-Based Post-Diagnostic Cancer Research Solution at American Association for Cancer Research (AACR) Annual Meeting 2023
Published: 2023-04-19 (Crawled : 21:00) - biospace.com/
ILMN | $122.74 -1.38% -1.4% 1.2M
|
Health Technology
|
| O: -1.0%
H: 2.76%
C: 2.48%
association solution positive cancer research meeting
GRAIL Presents New Data Demonstrating That Methylation Assay Detects Residual Hematologic Cancer After Treatment at American Association for Cancer Research (AACR) Annual Meeting 2023
Published: 2023-04-17 (Crawled : 23:00) - biospace.com/
ILMN | $122.74 -1.38% -1.4% 1.2M
|
Health Technology
|
| O: 0.45%
H: 0.5%
C: 0.41%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -0.14%
H: 0.08%
C: -0.18%
association cancer treatment research meeting
GRAIL CCGA Discovery Results Published in Cancer Cell Reveal Methylation as Promising DNA Hallmark for Multi-Cancer Early Detection
Published: 2022-11-17 (Crawled : 22:00) - biospace.com/
ILMN | $122.74 -1.38% -1.4% 1.2M
|
Health Technology
|
| O: -2.93%
H: 2.02%
C: -0.14%
dna cancer
GRAIL to Present Final Multi-cancer Early Detection Data From the Interventional PATHFINDER Study at ESMO Congress 2022
Published: 2022-09-08 (Crawled : 01:00) - biospace.com/
ILMN | $122.74 -1.38% -1.4% 1.2M
|
Health Technology
|
| O: -1.79%
H: 2.7%
C: 2.59%
study
GRAIL and England’s National Health Service (NHS) Present Trial Design for Largest Study of Multi-Cancer Early Detection Test at ASCO Annual Meeting
Published: 2022-06-06 (Crawled : 16:00) - biospace.com/
ILMN | $122.74 -1.38% -1.4% 1.2M
|
Health Technology
|
| O: 2.16%
H: 0.32%
C: -4.79%
test service health trial asco designation
GRAIL Announces Partnership with Alignment Health Plan as First Medicare Advantage Plan to Offer Galleri® Multi-Cancer Early Detection Blood Test
Published: 2021-12-06 (Crawled : 13:00) - biospace.com/
ALHC | $5.19 0.19% 0.19% 590K
|
|
| O: -7.69%
H: 0.0%
C: 0.0%
ILMN | $122.74 -1.38% -1.4% 1.2M
|
Health Technology
|
| O: -4.2%
H: 0.0%
C: 0.0%
partnership blood test cancer
GRAIL Receives New York State Approval for Galleri Multi-Cancer Early Detection Blood Test
Published: 2021-09-20 (Crawled : 15:00) - biospace.com/
ILMN | $122.74 -1.38% -1.4% 1.2M
|
Health Technology
|
| O: -1.42%
H: 2.11%
C: -0.61%
blood test cancer approval
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.